Cardiome -- CRME | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cardiome -- CRME

An SI Board Since July 2006

Posts	SubjectMarks	Bans	Symbol
285	19	0	CRME

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
110	I thought this was due in November, so I'd quit selling PUTs not expecting t	Ian@SI	-	12/18/2006
109	Thanks! Cheers, Tuck	tuck	-	12/12/2006
108	resubmission of their New Drug Application for IV vernakalant(Yukky name:-)). Th	dr.praveen	-	12/12/2006
107	For some reason, I am thinking there is news due within a month. I can't re	tuck	-	12/12/2006
106	Conversion agents have been approved looking primarily at conversion rates for e	kenhott	-	11/29/2006
105	Isn't it a little strange that they're now starting to look at time to r	former_pgs	-	11/22/2006
104	Thanks. CRME is the 2nd Cdn company with a promising drug and non US trial site	Ian@SI	-	11/22/2006
103	Nope...I heard the european sites suite better coz of the regulations here in US	dr.praveen	-	11/22/2006
102	Dr P., Do you know if there are there any US sites in any of their trials? TIA	Ian@SI	-	11/22/2006
101	Not sure if they gave one. I also like the new safety data they put for the IV v	dr.praveen	-	11/22/2006
100	What reason did they give to go from 600mg to 500mg??	kenhott	-	11/22/2006
99	"On the 3Q conference call, Cardiome provided details on the design of the	dr.praveen	-	11/22/2006
98	This was part of the "computer ate my homework" post that I'd trie	kenhott	-	11/2/2006
97	They charge 11K$ for the report:-) And in the next month or so, you can see the	dr.praveen	-	11/1/2006
96	<believes P&G Pharma’s Stedicor (azimilide) will be the highest...> l	kenhott	-	11/1/2006
95	Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COME	dr.praveen	-	10/31/2006
94	Atrial fibrillation: Azimilide is slightly superior to placebo but significantly	dr.praveen	-	10/31/2006
93	Antiarrhythmics: RSD1235 woes reduce market potential but not clinical impact	dr.praveen	-	10/31/2006
92	ACEP: Investigational Drug Converts Afib to Sinus Rhythm BY Neil Osterweil, Sen	dr.praveen	-	10/17/2006
91	Yup, so I bought some more. Serious support in the $9.25 region, where I'd	tuck	-	10/13/2006
90	Looks like the knife is still falling:-( :-) Don't you think the st is over	dr.praveen	-	10/13/2006
89	Fess up: Did you sell the 12.5s or the 10s? If the latter, it might be worth r	tuck	-	10/11/2006
88	I might get my first tranche next Friday. :(	Ian@SI	-	10/11/2006
87	Thats a good move...eom	dr.praveen	-	10/11/2006
86	I bought my first chunk today ($10.35) after this news of a shelf: >>VANC	tuck	-	10/11/2006

Go to reply# or date (mm/dd/yy):